Ageing or aging is the process of becoming older until our bodies can no longer function properly and will stop working at some point.The most accepted theory, to this date, is that aging is the accumulation of damage that happens to the body of living things as time progresses, and their lives keep going until there is enough damage that they can no longer resist.This “accumulation of damage” is what causes cells, organisms and whole systems of the body to fail, while there also exist internal causes of damage that help deteriorate the tissues of the body over time.However, an extensive study of the doctor Mikhail V. Blagosklonny has shown that this is not actually the case, but something completely different might be the cause of cancer as we know of it today.
According to his studies, aging is not an accumulation of damage, but it is a continuation of the process of growth that is experienced in the youth of men and women.As life progresses, the bodies of living beings grow as much as their DNA dictates, and their alimentation provides, but the DNA also dictates when the growth stops happening and the systems of the body start moving towards a period of life where deterioration happens naturally. One can live their lives eating healthily and not having external damage at all, but their body will still age because it is the natural course of what happens to all living beings.With these discoveries, however, Dr. Mikhail V. Blagosklonny has furthered his research into developing the next-gen anti-aging drug. As much as it sounds fantastic and utopic, the expert is actually reaching positive results to what might be the first remedy that actually slows down aging and prevents diseases that come with the process.
According to the specialist, the hyperfunction theory, as he likes to call it, allows scientists to now understand where the aging code comes from, and it can be traced back to signaling pathways such as what they call “TOR,” which stands for “Target of Rapamycin,” the name of the drug that is the scientist Blagosklonny developed Oncotarget .While it is an anti-aging drug of sorts, people might think that this is will make humans have some sort of immortal beings. Dr. Mikhail V. Blagosklonny addresses this issue when he explains that the drug he is developing simply slows down aging to abolish diseases like cancer that happen to old people more than younger ones. These diseases will not be the causes of death anymore, at least not of the same magnitude that it has been for years, but there will always exist additional events that cause the death of individuals.The TOR-Centric Model, which comprise the pathway that is essential for the growth and development of human beings, can be found in three different sources currently. The first one being the person’s genetics; the second being the cellular senescence (when the cycle of our body cells is blocked) because the rapamycin suppresses geroconversion. The third and last source of the TOR-Centric model are diseases like Parkinson and Alzheimer, for the surprise of most scientists.Today, Dr. Mikhail V. Blagosklonny is still furthering his researches to find out more about aging and the diseases that come with it.
Eric Paul Lefkofsky is a Chicago based entrepreneur, philanthropist and author. He began his entrepreneurial journey in 1993, after graduating from the University of Michigan where he studied law. Lefkofsky, together with his friend, Brad Keywell, began a company called Brandin Apparel where they sold carpets to their friends and college mates. The success of this venture gave him hope and a strong conviction that he could make it in the aggressive health care business world. He went ahead to launch various other companies like Groupon where he acted as its chairman and chief executive officer and Staberbelly. He also launched InnerWorkings in 2001 and Echo Global Logistics in 2005. The company was led with so much charisma and success that it attracted the New Enterprise Asociates and later on went public on NASDAQ.
Lefkosky’s greatest achievements is seen through the risk he took to begin a health company called Tempus. Having little knowledge on medicine and health, he began reading books and partnered with the right people to begin Tempus. Tempus is a tech company that provides solutions to doctors and physicians to help cure cancer. The company collects data and analyses it, after which the data is availed to the physicians who use it to help their patients who may be suffering from similar cases or tumour. Since its initiation in 2015, Lefkofsky has been the chief operating officer and its cofounder and has used his entrepreneurial skills to keep organization running, profitable and impactful to the society.
Lefkosky and his family are also popularly known for their commitment to helping their communities and impacting lives. Lefkofsky is engaged in various charity organizations where he spends both resources and time in. he began the Eric Lefkofsky Foundation in 2006, which is purposed to support organizations that are involved in charity science and education courses. He also supports and funds the Giving Pledge charity organization that is determined to provide food, clothing, shelter and medical supplies to those in need.
Lefkofsky is a man of many talents. Besides being a great leader, humanitarian he has also authored a book called the Accelerated Disruption which gives leaders insights on management of their businesses.
There are so many people who struggle on finding out what kind of treatments are best for you. Countless people and even physicians sometimes need that instant help in order to know what a person needs for their body and health. With the help of the Cancer Treatment Center of America working towards fixing this with new technology, they are definitely finding one solution one step at a time. They recently have released the Clinical Pathways program that is going to change how doctors work together with their patients in terms of what to do with their cancer.
According to Wikipedia, Clinical Pathways is a new solution that is going to update everybody in real-time what a patient needs based on their current state of health. Things like how their health is coping at the moment is going to be measured to ensure that any type of recommendations given is perfect for their health. All the cancer is tough to deal with, and Clinical Pathways is going to give physicians up to date knowledge on what to remember regarding what is best for their patients. There are custom treatment regimens available, comparisons between the options, alongside what knowing what is safe and most efficient for them. There is also a quick look at what is most cost-effective to think about regarding their health.
This Cancer Treatment Center of America is mainly focused on providing adults with solutions and treatments for their cancer. They aim to provide an integrative approach to combine powerful solutions for overcoming all kinds of cancer with advanced treatments, radiation, chemotherapy, and other forms of therapy to help adults overcome their biggest obstacles with their health. It’s important that they stay on their toes to help provide their patients with results, and they do it every day in all of their hospitals nationwide.
For more information follow Cancer Treatment Centers of America on Facebook.